可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Hansson L, Lindholim LH, Ekbom T, et al. Randomised trialof old and new antihypertensive drugs in elderly patients:cardiovascular mortality and morbidity in the swedish trial in old patients woth hypertension-2 study [J] . Lancet, 1999, 354:1751-1756.
[2] Hansson L, Zanchetti A. Effects of intensive blood-pressure lower in gand low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment(HOT) randomised trial [J] . Lancet, 1998, 351:1755-1762.
[3] UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS. 38 [J] . BMJ, 1998, 317:703-713.
[4] 曾广民, 蔡云峰. 从价效医学评价抗高血压药物的选择 [J] . 医学临床研究, 2002, 10:321-324.
[5] Brown MJ, Palmer CR, Castaogme A, et al. Morbidity and mortality in patients randomized to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: intervention as a Goalin Hypertension Treatment (Insight) [J] . Lancet, 2000, 356:366-372.
[6] 曾广民, 谢辉, 羊光杰, 等. 价效医学在高血压治疗中的意义 [J] . 岭南心血管病杂志, 2002, 8:12-1.